DE69736814D1 - Adipogenische differenzierung von humanen mesenchymalen stammzellen - Google Patents

Adipogenische differenzierung von humanen mesenchymalen stammzellen

Info

Publication number
DE69736814D1
DE69736814D1 DE69736814T DE69736814T DE69736814D1 DE 69736814 D1 DE69736814 D1 DE 69736814D1 DE 69736814 T DE69736814 T DE 69736814T DE 69736814 T DE69736814 T DE 69736814T DE 69736814 D1 DE69736814 D1 DE 69736814D1
Authority
DE
Germany
Prior art keywords
mesenchymal stem
stem cells
differentiate
cells
human mesenchymal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69736814T
Other languages
English (en)
Other versions
DE69736814T2 (de
Inventor
F Pittenger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of DE69736814D1 publication Critical patent/DE69736814D1/de
Application granted granted Critical
Publication of DE69736814T2 publication Critical patent/DE69736814T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
DE69736814T 1996-07-30 1997-07-21 Adipogenische differenzierung von humanen mesenchymalen stammzellen Expired - Lifetime DE69736814T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US700753 1996-07-30
US08/700,753 US5827740A (en) 1996-07-30 1996-07-30 Adipogenic differentiation of human mesenchymal stem cells
PCT/US1997/012356 WO1998004682A1 (en) 1996-07-30 1997-07-21 Adipogenic differentiation of human mesenchymal stem cells

Publications (2)

Publication Number Publication Date
DE69736814D1 true DE69736814D1 (de) 2006-11-23
DE69736814T2 DE69736814T2 (de) 2007-08-16

Family

ID=24814738

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69736814T Expired - Lifetime DE69736814T2 (de) 1996-07-30 1997-07-21 Adipogenische differenzierung von humanen mesenchymalen stammzellen

Country Status (11)

Country Link
US (3) US5827740A (de)
EP (2) EP1659172A1 (de)
JP (1) JP2001523084A (de)
AT (1) ATE342349T1 (de)
AU (1) AU3729097A (de)
CA (1) CA2262014C (de)
DE (1) DE69736814T2 (de)
DK (1) DK0954565T3 (de)
ES (1) ES2274547T3 (de)
PT (1) PT954565E (de)
WO (1) WO1998004682A1 (de)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
EP0974648A4 (de) * 1997-03-07 2002-11-20 Chugai Pharmaceutical Co Ltd Neuartige zellinie und screeningverfahren unter verwendung derselben
US6153432A (en) * 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
KR100979664B1 (ko) * 1999-03-10 2010-09-02 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 지방 유래 간세포 및 격자
US20050076396A1 (en) * 1999-03-10 2005-04-07 Katz Adam J. Adipose-derived stem cells and lattices
US20050158289A1 (en) * 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US8062675B2 (en) * 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
EP2348104A1 (de) 1999-08-05 2011-07-27 Mcl Llc Multipotente adulte Stammzellen und Isolierungsverfahren
JP2003517858A (ja) * 1999-11-05 2003-06-03 ジェリジーン メディカル コーポレーション 老齢関連の軟組織の欠陥の増強と修復
US6653146B1 (en) 1999-11-15 2003-11-25 Chemclean Corporation Bio-burden visualization system
US20020012905A1 (en) 2000-06-14 2002-01-31 Snodgrass H. Ralph Toxicity typing using liver stem cells
EP1303589B1 (de) * 2000-07-18 2007-09-12 Société des Produits Nestlé S.A. Pre-adipose zelllinien
AU2020902A (en) 2000-12-06 2002-06-18 Robert J Hariri Method of collecting placental stem cells background of the invention
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
US6869766B2 (en) * 2000-12-22 2005-03-22 The Regents Of The University Of California Gene associated with regulation of adiposity and insulin response
ES2549161T3 (es) 2001-02-14 2015-10-23 Anthrogenesis Corporation Placenta post-parto de mamífero, su uso y células madre placentarias de la misma
IL157350A0 (en) * 2001-02-14 2004-02-19 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US20060204556A1 (en) * 2001-12-07 2006-09-14 Cytori Therapeutics, Inc. Cell-loaded prostheses for regenerative intraluminal applications
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
BR0214772A (pt) * 2001-12-07 2007-01-09 Macropore Biosurgery Inc sistemas e métodos para o tratamento de pacientes com células lipoaspiradas processadas
US20030162707A1 (en) * 2001-12-20 2003-08-28 Fraser John K. Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
AU2003210447B2 (en) * 2002-01-04 2008-02-07 Henry Ford Health System Nitric oxide donors for treatment of disease and injury
KR20040101220A (ko) * 2002-02-07 2004-12-02 더 유니버시티 오브 마이애미 중추신경계 신경 재생을 촉진하는 슈반 세포 브리지임플란트 및 포스포디에스테라제 저해제
US20040076622A1 (en) * 2002-03-02 2004-04-22 Board Of Regents, The University Of Texas System Local production and/or delivery of anti-cancer agents by stromal cell precursors
US20050250202A1 (en) * 2002-03-19 2005-11-10 March Keith L Adipose stromal stem cells for tissue and vascular modification
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
US20040092011A1 (en) * 2002-04-03 2004-05-13 Wilkison William O. Adipocytic differentiated adipose derived adult stem cells and uses thereof
US7060494B2 (en) * 2002-04-09 2006-06-13 Reliance Life Sciences Pvt. Ltd. Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof
CA2481385A1 (en) * 2002-04-12 2003-10-23 Celgene Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
KR20050008757A (ko) * 2002-05-30 2005-01-21 셀진 코포레이션 세포 분화를 조절하고 골수증식성 질환 및 골수형성이상증후군을 치료하기 위하여 jnk 또는 mkk 저해제를사용하는 방법
KR101042448B1 (ko) * 2002-11-26 2011-06-16 안트로제네시스 코포레이션 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
CA2515594A1 (en) * 2003-02-13 2004-08-26 Anthrogenesis Corporation Use of umbilical cord blood to treat individuals having a disease, disorder or condition
KR100865884B1 (ko) 2003-03-18 2008-10-31 (주)안트로젠 동종 이식에 사용하기 위한 분화된 지방 세포
EP1608411B1 (de) * 2003-04-01 2010-09-29 United States Government as represented by the Department of Veteran's Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
EP1702062A2 (de) * 2003-06-11 2006-09-20 Jan Remmereit Kern-umprogrammierung von zellen für die therapeutische verwendung
US7012273B2 (en) * 2003-08-14 2006-03-14 Silicon Storage Technology, Inc. Phase change memory device employing thermal-electrical contacts with narrowing electrical current paths
US7569385B2 (en) * 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
WO2005033297A1 (en) * 2003-09-19 2005-04-14 The Rockefeller University Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
JP2007508018A (ja) 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
US7829332B2 (en) * 2004-02-13 2010-11-09 Cornell Research Foundation, Inc. Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom
CA2563518C (en) 2004-04-23 2014-09-02 Bioe, Inc. Multi-lineage progenitor cells
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
AU2005287855B2 (en) * 2004-09-24 2011-06-16 Mesoblast, Inc. Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)
AU2005304687B2 (en) 2004-11-11 2012-01-19 The General Hosptial Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
US20060134781A1 (en) * 2004-12-07 2006-06-22 Bacterin International, Inc. Three-dimensional cell culture system
CA2512667A1 (en) * 2005-01-07 2006-07-07 Takahiro Ochiya Human hepatocyte-like cells and uses thereof
US20080140451A1 (en) * 2005-01-10 2008-06-12 Cytori Therapeutics, Inc. Devices and Methods for Monitoring, Managing, and Servicing Medical Devices
US20080241112A1 (en) * 2005-05-10 2008-10-02 Christof Westenfelder Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media
US8613906B2 (en) 2005-05-27 2013-12-24 Viacord, Llc Treatment of ischemia using stem cells
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
US7531355B2 (en) 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
US7601699B2 (en) * 2005-08-01 2009-10-13 Nupotential, Inc. Production of reprogrammed cells with restored potential
EP2796544B1 (de) 2005-09-09 2019-04-03 Duke University Gewebetechnologieverfahren und Zusammensetzungen
CN104138392A (zh) 2005-10-13 2014-11-12 人类起源公司 使用胎盘干细胞的免疫调节
US20080070303A1 (en) * 2005-11-21 2008-03-20 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
CA2633775A1 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
EP2471907B1 (de) 2005-12-29 2018-09-26 Celularity, Inc. Plazentastammzellenpopulationen
JP2009525044A (ja) * 2006-01-30 2009-07-09 ユニバーシティ オブ バージニア パテント ファウンデーション 間葉系幹細胞集合体を調製および特性評価する方法ならびにそれらの使用
EP2019858B1 (de) 2006-04-17 2012-06-13 BioE LLC Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen
WO2007139551A1 (en) * 2006-05-30 2007-12-06 Cytori Therapeutics, Inc. Systems and methods for manipulation of regenerative cells from adipose tissue
CA2654716A1 (en) * 2006-06-09 2007-12-21 Anthrogenesis Corporation Placental niche and use thereof to culture stem cells
US20100015104A1 (en) * 2006-07-26 2010-01-21 Cytori Therapeutics, Inc Generation of adipose tissue and adipocytes
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008060374A2 (en) * 2006-10-06 2008-05-22 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
US8562972B2 (en) 2006-10-23 2013-10-22 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
TW200822930A (en) * 2006-11-22 2008-06-01 Chao-Song Hsue Composition for reducing weight and curing hypertriglyceridemia, the effective ingredients thereof containing cyclic AMP, nicotinic acid, prostaglandin, gamma linolenic acid, and xanthine derivates
EP2915537A3 (de) 2007-02-12 2015-10-28 Anthrogenesis Corporation Behandlung von Infektionskrankheiten mithilfe von Plazenta-Stammzellen
KR20090109127A (ko) 2007-02-12 2009-10-19 안트로제네시스 코포레이션 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 cd34+, cd45- 태반 줄기세포가 농축된 세포군
US7632340B2 (en) * 2007-03-07 2009-12-15 Hamilton Beach Brands, Inc. Air purifier for removing particles or contaminants from air
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
EP2607477B1 (de) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotente stammzellen und ihre verwendung
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
CA2693827A1 (en) * 2007-07-25 2009-01-29 Bioe, Inc. Differentiation of multi-lineage progenitor cells to chondrocytes
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
MX2010003217A (es) * 2007-09-26 2010-07-30 Celgene Cellular Therapeutics Celulas angiogenicas de perfundido de placenta humana.
US8263065B2 (en) 2007-09-28 2012-09-11 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
JP2011503064A (ja) * 2007-11-07 2011-01-27 アンスロジェネシス コーポレーション 早産の合併症の治療
US20100278788A1 (en) * 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
US20100189338A1 (en) * 2008-04-09 2010-07-29 Nexcelom Bioscience Systems and methods for counting cells and biomolecules
CN102083969A (zh) * 2008-05-06 2011-06-01 乔斯林糖尿病中心股份有限公司 诱导褐色脂肪形成的方法和组合物
CN102016008A (zh) 2008-05-07 2011-04-13 骨治疗公司 间充质干细胞和骨形成细胞
CA2724839A1 (en) * 2008-05-21 2009-11-26 Bioe Llc Differentiation of multi-lineage progenitor cells to pancreatic cells
ES2608974T3 (es) * 2008-08-14 2017-04-17 Mesoblast International Sàrl Composiciones de células madre mesenquimales purificadas
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
WO2010021714A2 (en) 2008-08-20 2010-02-25 Anthrogenesis Corporation Improved cell composition and methods of making the same
JP5950577B2 (ja) 2008-08-20 2016-07-13 アンスロジェネシス コーポレーション 単離胎盤細胞を使用した脳卒中の治療
RU2011110736A (ru) 2008-08-22 2012-09-27 Антродженезис Корпорейшн (Us) Способы и композиции для лечения костных дефектов с помощью плацентарных клеточных популяций
EP2182055A1 (de) 2008-10-14 2010-05-05 Heinrich-Heine-Universität Düsseldorf Aus der menschlichen Nabelschnur gewonnene unrestringierte somatische Stammzellen (USSC)
US20100098739A1 (en) * 2008-10-20 2010-04-22 University Of Virginia Patent Foundation Compositions and methods for modular soft tissue repair
MX2011005229A (es) 2008-11-19 2011-06-16 Anthrogenesis Corp Celulas adherentes derivadas del amnios.
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
EP2375907B1 (de) * 2008-11-21 2019-02-27 Celularity, Inc. Behandlung von krankheiten, störungen oder leiden der lunge mittels plazentazellen
ES2625893T3 (es) 2009-05-01 2017-07-20 Bimini Technologies Llc Sistemas, procedimientos y composiciones para optimizar injertos enriquecidos con tejido y células
US9301975B2 (en) 2009-05-01 2016-04-05 Biocardia, Inc. Method of preparing autologous cells and method of use for therapy
JP2012531916A (ja) 2009-07-02 2012-12-13 アンソロジェネシス コーポレーション 支持細胞を用いない赤血球の生産方法
CN102625829B (zh) 2009-07-21 2015-05-06 Abt控股公司 干细胞用于减少白细胞外渗的用途
ES2690199T3 (es) 2009-07-21 2018-11-19 Abt Holding Company Uso de células madre para reducir la extravasación de leucocitos
WO2011043629A2 (ko) * 2009-10-08 2011-04-14 서울대학교병원 인간 지방 줄기세포의 고활성을 유도하는 방법 및 배지
WO2011043524A1 (ko) * 2009-10-08 2011-04-14 주식회사 알앤엘바이오 인간 유래 성체 줄기세포를 함유하는 항암용 조성물
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9121007B2 (en) 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
WO2011106521A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of macrophage activation
CN102933703A (zh) 2010-04-07 2013-02-13 人类起源公司 使用胎盘干细胞的血管生成
KR20130092394A (ko) 2010-04-08 2013-08-20 안트로제네시스 코포레이션 태반 줄기 세포를 사용한 사르코이드증의 치료
JP5968871B2 (ja) 2010-04-13 2016-08-10 セルラー ダイナミクス インターナショナル, インコーポレイテッド フォワードプログラミングによる肝細胞の産生
WO2011159797A2 (en) 2010-06-15 2011-12-22 Cellular Dynamics International, Inc. A compendium of ready-built stem cell models for interrogation of biological response
CA2804595C (en) 2010-07-07 2018-11-13 Cellular Dynamics International, Inc. Endothelial cell production by programming
US9206387B2 (en) 2010-07-09 2015-12-08 The Gid Group, Inc. Method and apparatus for processing adipose tissue
US9296984B2 (en) 2010-07-09 2016-03-29 The Gid Group, Inc. Tissue processing apparatus and method for processing adipose tissue
US9260697B2 (en) 2010-07-09 2016-02-16 The Gid Group, Inc. Apparatus and methods relating to collecting and processing human biological material containing adipose
WO2013106655A1 (en) 2012-01-11 2013-07-18 The Gid Group, Inc. Method for processing adipose tissue and processing apparatus
CN103097520B (zh) 2010-07-13 2017-12-05 人类起源公司 产生自然杀伤细胞的方法
CA2809847A1 (en) * 2010-09-01 2012-03-08 The Regents Of The University Of California Cell culture screen for agents that control adipogenesis and myofibroblast differentiation
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US9381219B2 (en) 2010-12-29 2016-07-05 Ethicon Endo-Surgery, Inc. Brown adipocyte modification
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
PL2667878T3 (pl) 2011-01-25 2016-10-31 Kompozycje i sposoby transplantacji komórek
US9574179B2 (en) 2011-02-08 2017-02-21 Cellular Dynamics International, Inc. Hematopoietic precursor cell production by programming
PT2714059T (pt) 2011-06-01 2019-02-04 Celularity Inc Tratamento da dor utilizando células estaminais da placenta
SG10201914092XA (en) 2011-06-06 2020-03-30 ReGenesys BVBA Expansion of stem cells in hollow fiber bioreactors
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
SG11201401434TA (en) 2011-10-11 2014-09-26 Bone Therapeutics Sa Uses of growth and differentiation factor 8 (gdf-8)
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes
ES2726802T3 (es) 2012-01-25 2019-10-09 Univ Catholique Louvain Composiciones y métodos para el trasplante celular
EP2832850B1 (de) 2012-03-29 2017-09-06 JCR Pharmaceuticals Co., Ltd. Verfahren zur herstellung pluripotenter stammzellen aus zahnzellstoff
EP3896145A1 (de) 2012-09-06 2021-10-20 GID BIO, Inc. Gewebeverarbeitungsvorrichtung und verfahren zur verarbeitung von fettgewebe
DK2900247T3 (en) 2012-09-26 2018-03-05 Bone Therapeutics Sa COMPOSITIONS OF SOLVENT / DETERGENT-TREATED PLASMA AND HYALURONIC ACID FOR USE IN TREATMENT OF MUSCULOSKELETAL DISORDERS
JP2016501866A (ja) 2012-11-25 2016-01-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 皮下脂肪生成を刺激するペプチド
CN115137753A (zh) 2013-02-05 2022-10-04 细胞结构公司 来自胎盘的自然杀伤细胞
CA2901747A1 (en) 2013-02-22 2014-08-28 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
CA2899713C (en) 2013-03-15 2022-07-19 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
CN105358680B (zh) 2013-04-03 2019-06-25 富士费勒姆细胞动力学有限公司 用于悬浮培养内胚层祖细胞的方法和组合物
HUE052516T2 (hu) 2013-04-12 2021-05-28 Houston Methodist Hospital Szervek javítása transzplantációhoz
ES2753323T3 (es) 2013-04-30 2020-04-08 Univ Leuven Kath Terapia celular para síndromes mielodisplásicos
EP3038629B1 (de) 2013-09-05 2020-11-18 GID BIO, Inc. Verfahren zur verarbeitung von fettgewebe
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3613841B1 (de) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passives ersetzen von medien
WO2015164228A1 (en) 2014-04-21 2015-10-29 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
WO2015184125A1 (en) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
EP3193953B1 (de) 2014-09-19 2020-03-11 Osiris Therapeutics, Inc. Knochenreparaturprodukt und verfahren zur verwendung davon
WO2016049156A1 (en) 2014-09-23 2016-03-31 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
KR101629151B1 (ko) * 2014-11-07 2016-06-10 한양대학교 에리카산학협력단 줄기세포 유래 엑소좀을 포함하는 지방세포 분화유도 및 지방조직 재생용 조성물
CN107106613B (zh) 2014-11-07 2021-07-06 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US20180110217A1 (en) 2015-04-23 2018-04-26 Bone Therapeutics S.A. In Vitro Preservation of Therapeutic Cells
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US20200325449A1 (en) 2016-06-02 2020-10-15 The Cleveland Clinic Foundation Complement inhibition for improving cell viability
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
KR20190046844A (ko) 2016-08-30 2019-05-07 라이프셀 코포레이션 의료 디바이스 제어를 위한 시스템 및 방법
USD851777S1 (en) 2017-01-30 2019-06-18 Lifecell Corporation Canister-type device for tissue processing
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
WO2019018002A1 (en) 2017-07-18 2019-01-24 The Gid Group, Inc. ADIPOSE TISSUE DIGESTION SYSTEM AND METHOD FOR TREATING TISSUE
AU2018351804B2 (en) 2017-10-20 2020-07-09 Bone Therapeutics Sa Methods for differentiating mesenchymal stem cells
US11530387B2 (en) 2017-11-16 2022-12-20 Nissan Chemical Corporation Method for inducing differentiation into and producing beige and white adipocytes
US20210301258A1 (en) 2018-07-31 2021-09-30 Jcr Pharmaceuticals Co., Ltd. Method for Producing Dental Pulp-Derived Cells
EP3856932A1 (de) 2018-09-25 2021-08-04 Bone Therapeutics S.A. Verfahren und verwendungen zur bestimmung des osteogenen potenzials von in vitro differenzierten zellen
JP2022501053A (ja) 2018-09-25 2022-01-06 ボーン、セラピューティクス、エスアーBone Thrapeutics Sa 間葉系幹細胞を分化させるための方法
AR118008A1 (es) 2019-02-07 2021-09-08 Vitricell Sa Composiciones para criopreservación de un material biológico
CN113825498A (zh) 2019-05-13 2021-12-21 骨治疗公司 包括透明质酸和血浆蛋白的改进冻干制剂及其用途
JP2022539249A (ja) 2019-07-05 2022-09-07 ケース ウェスタン リザーブ ユニバーシティ 幹細胞培養及び幹細胞治療用プライム化培地及びプライム化方法
TW202146033A (zh) 2020-01-30 2021-12-16 日商Jcr製藥股份有限公司 包含源自牙髓的細胞之醫藥組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells

Also Published As

Publication number Publication date
US6709864B1 (en) 2004-03-23
WO1998004682A1 (en) 1998-02-05
US6322784B1 (en) 2001-11-27
EP0954565A4 (de) 2002-09-18
ES2274547T3 (es) 2007-05-16
US5827740A (en) 1998-10-27
EP0954565B1 (de) 2006-10-11
CA2262014A1 (en) 1998-02-05
PT954565E (pt) 2007-01-31
JP2001523084A (ja) 2001-11-20
EP1659172A1 (de) 2006-05-24
ATE342349T1 (de) 2006-11-15
CA2262014C (en) 2010-09-14
DK0954565T3 (da) 2007-02-05
EP0954565A1 (de) 1999-11-10
AU3729097A (en) 1998-02-20
DE69736814T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
ATE342349T1 (de) Adipogenische differenzierung von humanen mesenchymalen stammzellen
DE60120151D1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
UA37191C2 (uk) Водна структурована композиція поверхнево-активної речовини
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE69636979D1 (de) Zellinien-gerichtete induktion der menschlichen mesenchymalen stammzelldifferenzierung
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
EP1100870A4 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
ID23877A (id) Senyawa-senyawa dan metode-metode untuk penghambatan ekspresi vcam-1
DE69905906T2 (de) Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen
DK0804163T3 (da) Forbedret fremgangsmåde til stabilisering af biologiske stoffer under tørring og efterfølgende opbevaring samt præparater deraf
MX9710479A (es) Extracto de iridaceas y composiciones que la contienen.
AR006160A1 (es) Composicion detergente que comprende alfa-amilasa de actividad especifica y su aplicacion para limpieza
DE69333931D1 (de) Verwendung von Krillenzymen zur Behandlung von Zahnbelag
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
DE69717101T2 (de) VERWENDUNG VON alpha-ALKYLGLUCOSIDEN UND DEREN ESTERN ALS ANTIMIKROBIELLE EMULGATOREN
WO2002051986A3 (en) Educated nk t cells and their uses in the treatment of immune-related disorders
BG103677A (en) Solid mixtures based on sulphonylcarbamides and adjuvants
WO2000033887A3 (en) Methods and formulations for reducing circulating antibodies
BR9814284A (pt) Composições e métodos para regulação de fagocitose e expressão de icam-1
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
ATE302264T1 (de) Freigabe von intrazellulärem material
WO1997000671A3 (de) Zusammensetzung zur herstellung feindisperser systeme und verfahren zu ihrer herstellung
WO1999031136A3 (en) Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DR. VOLKER VOSSIUS, CORINNA VOSSIUS, TILMAN VOSSIU